110931-72-1

Usage

Uses

Used in Organic Synthesis:
N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine is used as a reagent in organic synthesis for various chemical reactions, due to its unique structure and reactivity.
Used in Pharmaceutical Industry:
N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine is used as a pharmaceutical intermediate, playing a crucial role in the synthesis of various drugs and medications.
Used in Medical Research:
N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine has been investigated for its potential use in the treatment of various diseases and medical conditions, owing to its unique chemical properties and interactions with biological systems.
Safety Precautions:
It is important to handle N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine with caution, as it can be hazardous if inhaled, swallowed, or in contact with skin. Safety precautions should be taken when handling and storing N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine to minimize potential risks.

InChI:InChI=1/C14H15N/c1-15-11-12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-10,15H,11H2,1H3

Upstream product

• 1667-11-4 biphenyl-4-methylchloride 
• 74-89-5 methylamine 
• 3218-36-8 4-Phenylbenzaldehyde 
• 110951-66-1 methyl-[1]naphthylmethyl-(4-phenyl-benzyl)-amine 
• 856200-13-0 methyl-[2]naphthylmethyl-(4-phenyl-benzyl)-amine 
• 100866-10-2 methyl-(4-phenyl-benzyliden)-amine 
• 2567-29-5 p-phenylbenzyl bromide 
• 3597-91-9 biphenyl-4-yl methanol 

Downstream Products

• 857785-79-6 (4-cyclohexyl-benzyl)-methyl-(4-phenyl-benzyl)-amine 
• 233283-78-8 C₁₇H₁₉NO₄S 
• 486435-56-7 N-(biphenyl-4-yl)methyl-N-methyl-4-(4'-trifluoromethylbiphenyl-2-carbonylamino)-1-methyl-pyrrole-2-carboxylic acid amide 

Relevant academic research and scientific papers

Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones

A series of 1-(biphenylmethylamidoalkyl)-pyrimidones has been designed as nanomolar inhibitors of recombinant lipoprotein-associated phospholipase A2 with high potency in whole human plasma. 5-(Pyrazolylmethyl) derivative 16 and 5-(methoxypyrimidinylmethyl) derivative 27 demonstrated excellent pharmacodynamic profiles which correlated well with their pharmacokinetic effects.

Mono and double modified teicoplanin aglycon derivatives on the amino acid No. 7; Structure-activity relationship

A series of 7d-aminomethylated derivatives (mono modified) and their amides (double modified) at the amino acid No. 7 of teicoplanin aglycon were prepared with the aim of obtaining activity against vancomycin-resistant VanA enterococci. Among mono modified compounds, the 7d-n-decylaminomethyl derivative was the most active against VanA enterococci (4 μg/ml). Amides of the latter with 3-dimethylamino-propylamine or methylamine were found to be up to four times more active against glycopeptide-susceptible Gram-positive bacteria, and up to four times less active against VanA enterococci than the starting compound.

A new type of chemical modification of glycopeptides antibiotics: Aminomethylated derivatives of eremomycin and their antibacterial activity

A series of derivatives of eremomycin aminomethylated at the 7d position of the resorcinol ring of the amino acid No. 7 was prepared by interaction of eremomycin with formaldehyde and various primary and secondary amines and ammonia. The most active compo

Amine derivatives, processes for their production and their use

Compounds of formula I STR1 wherein R1 represents a group of formula STR2 and R2 represents hydrogen or lower alkyl, or R1 and R2 together with the carbon atom to which they are attached represent a group of for